1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest

Prostate

Volumn 71, Issue 1, 2011, Pages 98-110

  Washington, Michele N ^a   Kim, Jung Sun ^a   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

c Myc; E2F; prostate cancer; Rb; vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; DRUG RESPONSE; GENE EXPRESSION; GENE TARGETING; HETEROZYGOSITY LOSS; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL;

CALCITRIOL; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, MYC; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN;

EID: 78649559230     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21226     Document Type: Article

References (48)

1. Huynh H, Pollak M, Zhang JC,. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. Int J Oncol 1998; 13 (1): 137-143.
2. Boyle BJ, Zhao XY, Cohen P, Feldman D,. Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol 2001; 165 (4): 1319-1324.
3. Tovar Sepulveda VA, Falzon M,. Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells. Mol Cell Endocrinol 2002; 190 (1-2): 115-124.
4. Blutt SE, McDonnell TJ, Polek TC, Weigel NL,. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 2000; 141 (1): 10-17.
5. Blutt SE, Allegretto EA, Pike JW, Weigel NL,. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 1997; 138 (4): 1491-1497.
6. Zhuang SH, Burnstein KL,. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 1998; 139 (3): 1197-1207.
7. Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Grana X, Giordano A, Calabretta B,. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res 1994; 54 (6): 1402-1406.
8. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR,. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65 (6): 1053-1061.
9. Weintraub SJ, Prater CA, Dean DC,. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992; 358 (6383): 259-261.
10. Rohan JN, Weigel NL,. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology 2009; 150 (5): 2046-2054.
11. Leung JY, Ehmann GL, Giangrande PH, Nevins JR,. A role for Myc in facilitating transcription activation by E2F1. Oncogene 2008; 27 (30): 4172-4179.
12. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ,. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7 (3): 331-342.
13. Lundberg AS, Weinberg RA,. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18 (2): 753-761.
14. Mateyak MK, Obaya AJ, Sedivy JM,. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19 (7): 4672-4683.
15. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G, Eilers M,. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 1993; 90 (8): 3685-3689.
16. Galaktionov K, Chen X, Beach D,. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996; 382 (6591): 511-517.
17. Claassen GF, Hann SR,. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc Natl Acad Sci USA 2000; 97 (17): 9498-9503.
18. Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD,. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res 2004; 64 (6): 2143-2147.
19. Moffatt KA, Johannes WU, Hedlund TE, Miller GJ,. Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res 2001; 61 (19): 7122-7129.
20. 3. Int J Oncol 1996; 8: 41-47.
21. Skowronski RJ, Peehl DM, Feldman D,. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132 (5): 1952-1960.
22. Polek TC, Stewart LV, Ryu EJ, Cohen MB, Allegretto EA, Weigel NL,. p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Endocrinology 2003; 144 (1): 50-60.
23. Phillips SM, Barton CM, Lee SJ, Morton DG, Wallace DM, Lemoine NR, Neoptolemos JP,. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 1994; 70 (6): 1252-1257.
24. Ittmann MM, Wieczorek R,. Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas. Hum Pathol 1996; 27 (1): 28-34.
25. Tricoli JV, Gumerlock PH, Yao JL, Chi SG, D'Souza SA, Nestok BR, deVere White RW,. Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer 1996; 15 (2): 108-114.
26. Brooks JD, Bova GS, Isaacs WB,. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate 1995; 26 (1): 35-39.
27. Agoulnik IU, Krause WC, Bingman WE, 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL,. Repressors of androgen and progesterone receptor action. J Biol Chem 2003; 278 (33): 31136-31148.
28. Bai W, Weigel NL,. Phosphorylation of Ser211 in the chicken progesterone receptor modulates its transcriptional activity. J Biol Chem 1996; 271 (22): 12801-12806.
29. Stewart LV, Weigel NL,. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Prostate 2005; 64 (1): 9-19.
30. Narayanan R, Edwards DP, Weigel NL,. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol Cell Biol 2005; 25 (8): 2885-2898.
31. Huang H, Zegarra-Moro OL, Benson D, Tindall DJ,. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells. Oncogene 2004; 23 (12): 2161-2176.
32. Suzuki S, Adachi A, Hiraiwa A, Ohashi M, Ishibashi M, Kiyono T,. Cloning and characterization of human MCM7 promoter. Gene 1998; 216 (1): 85-91.
33. Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Berges J, Helin K, Jansen-Durr P, Henglein B,. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci USA 1995; 92 (24): 11264-11268.
34. Ohtani K, DeGregori J, Nevins JR,. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 1995; 92 (26): 12146-12150.
35. Yen A, Chandler S, Forbes ME, Fung YK, T'Ang A, Pearson R,. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: Possible role of RB as a "status quo" gene. Eur J Cell Biol 1992; 57 (2): 210-221.
36. Jiang F, Li P, Fornace AJ, Jr., Nicosia SV, Bai W,. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 2003; 278 (48): 48030-48040.
37. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornace AJ, Jr., Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 1996; 13 (10): 2255-2263.
38. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ, Jr., Harris CC,. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999; 96 (7): 3706-3711.
39. Jiang F, Wang Z,. Gadd45gamma is androgen-responsive and growth-inhibitory in prostate cancer cells. Mol Cell Endocrinol 2004; 213 (2): 121-129. (Pubitemid 38210045)
40. Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, Qian DZ, Beer TM,. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin Cancer Res 2008; 14 (11): 3562-3570.
41. Welcker M, Clurman BE,. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4. J Biol Chem 2005; 280 (9): 7654-7658.
42. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI,. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23 (10): 2116-2125.
43. Wade WN, Willingham MC, Koumenis C, Cramer SD,. p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblasts. J Biol Chem 2002; 277 (40): 37301-37306.
44. Pan Q, Martell RE, O'Connell TD, Simpson RU,. 1,25-Dihydroxyvitamin D3-regulated binding of nuclear proteins to a c-myc intron element. Endocrinology 1996; 137 (10): 4154-4160.
45. Pan Q, Simpson RU,. c-Myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J Biol Chem 1999; 274 (13): 8437-8444.
46. Mangasarian K, Mellon WS,. 1,25-Dihydroxyvitamin D-3 destabilizes c-myc mRNA in HL-60 leukemic cells. Biochim Biophys Acta 1993; 1172 (1-2): 55-63.
47. Simpson RU, Hsu T, Begley DA, Mitchell BS, Alizadeh BN,. Transcriptional regulation of the c-myc protooncogene by 1,25-dihydroxyvitamin D3 in HL-60 promyelocytic leukemia cells. J Biol Chem 1987; 262 (9): 4104-4108.
48. Lin Y, Fukuchi J, Hiipakka RA, Kokontis JM, Xiang J,. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage. Cell Res 2007; 17 (6): 531-536.